Wound Management Technologies Expands Distribution Foot Print In Florida With The Addition Of Central Medical Systems

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced that its subsidiary Wound Care Innovations, LLC has further expanded its rapidly growing coverage of the Florida wound care market with the addition of Central Medical Systems to its already extensive list of distributors and suppliers. "A company like CMSI is the ideal type of distributor; they have credibility and an established history in the market and understand the business of wound care especially for diabetic patients. I look forward to a very fruitful relationship," stated Ron Mathis, Sr. VP of Marketing and Sales for Wound Care Innovations, LLC.


Trent Harley, President of Central Medical Systems was quoted as saying, "We are excited to be a new distributor for Cellerate RX®. Over the past year, CMSI has observed the demand for Cellerate RX® outpacing the growth of other collagen-based wound care products being sold in the Florida market."


Central Medical Systems of Winter Park, Florida is a full service medical supply company, serving the wound care professional, and patients in need of wound care or diabetic supplies.


Safe Harbor Statement:


The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.